• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环孢素可增加杜氏肌营养不良症患者的肌肉力量生成。

Cyclosporine increases muscular force generation in Duchenne muscular dystrophy.

作者信息

Sharma K R, Mynhier M A, Miller R G

机构信息

Department of Neuromuscular Research, California Pacific Medical Center, San Francisco 94118.

出版信息

Neurology. 1993 Mar;43(3 Pt 1):527-32. doi: 10.1212/wnl.43.3_part_1.527.

DOI:10.1212/wnl.43.3_part_1.527
PMID:8450995
Abstract

We investigated the effect of cyclosporine (CsA) on force generation in 15 boys with Duchenne muscular dystrophy (DMD) by obtaining monthly measures of tetanic force and maximum voluntary contraction (MVC) of both anterior tibial muscles. During 4 months of a natural history phase, both tetanic force and MVC declined significantly. During 8 weeks of CsA treatment (5 mg/kg/day), significantly increased tetanic force (25.8 +/- 6.6%) and MVC (13.6 +/- 4.0%) occurred within 2 weeks. The maximum mean increase during treatment was 35.2 +/- 5.9% (tetanic force) and 19.0 +/- 4.6% (MVC). Side effects from CsA, gastrointestinal and flu-like symptoms, were transient and self-limiting. Thus, as previously reported with prednisone, CsA increases muscular force generation in the anterior tibial muscles of DMD patients.

摘要

我们通过每月测量15名杜氏肌营养不良症(DMD)男孩双侧胫骨前肌的强直收缩力和最大自主收缩(MVC),研究了环孢素(CsA)对其肌力产生的影响。在4个月的自然病程阶段,强直收缩力和MVC均显著下降。在CsA治疗8周(5mg/kg/天)期间,2周内强直收缩力(25.8±6.6%)和MVC(13.6±4.0%)显著增加。治疗期间最大平均增幅为35.2±5.9%(强直收缩力)和19.0±4.6%(MVC)。CsA的副作用,如胃肠道和流感样症状,是短暂的且可自行缓解。因此,正如先前使用泼尼松的报道一样,CsA可增加DMD患者胫骨前肌的肌力产生。

相似文献

1
Cyclosporine increases muscular force generation in Duchenne muscular dystrophy.环孢素可增加杜氏肌营养不良症患者的肌肉力量生成。
Neurology. 1993 Mar;43(3 Pt 1):527-32. doi: 10.1212/wnl.43.3_part_1.527.
2
Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study.
Muscle Nerve. 1997 Apr;20(4):469-78. doi: 10.1002/(sici)1097-4598(199704)20:4<469::aid-mus10>3.0.co;2-u.
3
Muscular fatigue in Duchenne muscular dystrophy.杜氏肌营养不良症中的肌肉疲劳
Neurology. 1995 Feb;45(2):306-10. doi: 10.1212/wnl.45.2.306.
4
Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys.
Cell Transplant. 1992;1(2-3):235-44. doi: 10.1177/0963689792001002-305.
5
Long-term electrical stimulation of muscles in children with Duchenne and Becker muscular dystrophy.对杜氏和贝克氏肌肉营养不良症患儿肌肉进行长期电刺激。
Muscle Nerve. 1992 Mar;15(3):362-7. doi: 10.1002/mus.880150316.
6
Long-term benefit from prednisone therapy in Duchenne muscular dystrophy.泼尼松治疗杜氏肌营养不良症的长期益处。
Neurology. 1991 Dec;41(12):1874-7. doi: 10.1212/wnl.41.12.1874.
7
Selenium and vitamin E treatment of Duchenne muscular dystrophy: no effect on muscle function.硒和维生素E治疗杜氏肌营养不良症:对肌肉功能无影响。
Acta Neurol Scand. 1988 Nov;78(5):429-35. doi: 10.1111/j.1600-0404.1988.tb03681.x.
8
[Myometric evaluation of patients with Duchenne muscular dystrophy].
Arq Neuropsiquiatr. 1995 Jun;53(2):233-7. doi: 10.1590/s0004-282x1995000200008.
9
Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy.杜氏肌营养不良症肌肉组成与功能的定量磁共振弛豫测量研究
J Magn Reson Imaging. 1994 Jan-Feb;4(1):59-64. doi: 10.1002/jmri.1880040113.
10
Responses of muscles of patients with Duchenne muscular dystrophy to chronic electrical stimulation.杜兴氏肌肉营养不良症患者的肌肉对慢性电刺激的反应。
J Neurol Neurosurg Psychiatry. 1986 Dec;49(12):1427-34. doi: 10.1136/jnnp.49.12.1427.

引用本文的文献

1
A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy.网络医学方法在杜氏肌营养不良症药物再利用中的应用。
Genes (Basel). 2021 Apr 9;12(4):543. doi: 10.3390/genes12040543.
2
Recent advances in Duchenne muscular dystrophy.杜氏肌营养不良症的最新进展
Degener Neurol Neuromuscul Dis. 2012 Oct 11;2:141-164. doi: 10.2147/DNND.S26637. eCollection 2012.
3
Pharmacological therapeutics targeting the secondary defects and downstream pathology of Duchenne muscular dystrophy.针对杜氏肌营养不良症继发性缺陷和下游病理的药物治疗学。
Expert Opin Orphan Drugs. 2016;4(11):1179-1194. doi: 10.1080/21678707.2016.1240613. Epub 2016 Oct 18.
4
Corticosteroids for the treatment of Duchenne muscular dystrophy.用于治疗杜氏肌营养不良症的皮质类固醇
Cochrane Database Syst Rev. 2016 May 5;2016(5):CD003725. doi: 10.1002/14651858.CD003725.pub4.
5
Immune-mediated pathology in Duchenne muscular dystrophy.杜氏肌营养不良症中的免疫介导病理学。
Sci Transl Med. 2015 Aug 5;7(299):299rv4. doi: 10.1126/scitranslmed.aaa7322.
6
Molecular Dissection of Cyclosporin A's Neuroprotective Effect Reveals Potential Therapeutics for Ischemic Brain Injury.分子剖析环孢素 A 的神经保护作用,揭示治疗缺血性脑损伤的潜在疗法。
Brain Sci. 2013 Sep 5;3(3):1325-56. doi: 10.3390/brainsci3031325.
7
Microdystrophin ameliorates muscular dystrophy in the canine model of duchenne muscular dystrophy.微 dystrophin 改善杜氏肌营养不良症犬模型的肌肉营养不良。
Mol Ther. 2013 Apr;21(4):750-7. doi: 10.1038/mt.2012.283. Epub 2013 Jan 15.
8
Effects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy.免疫抑制治疗对杜氏肌营养不良症 GRMD 犬模型的影响。
PLoS One. 2012;7(11):e48478. doi: 10.1371/journal.pone.0048478. Epub 2012 Nov 21.
9
Debio-025 is more effective than prednisone in reducing muscular pathology in mdx mice.Debio-025 在减少 mdx 小鼠的肌肉病理方面比泼尼松更有效。
Neuromuscul Disord. 2010 Nov;20(11):753-60. doi: 10.1016/j.nmd.2010.06.016. Epub 2010 Jul 15.
10
Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy.亲环素抑制剂Debio 025在杜氏肌营养不良症模型——营养不良性mdx小鼠中的研究。
Br J Pharmacol. 2008 Oct;155(4):574-84. doi: 10.1038/bjp.2008.285. Epub 2008 Jul 21.